TipRanks
Go Ultimate55% OFF

Modern Healthcare Technology Holdings Limited (0919) AI Stock Analysis

Top Page

HK:0919

Modern Healthcare Technology Holdings Limited

(HKEX:0919)

Select Model
Rating:51Neutral
Price Target:HKD 0.08â–²(10.67% Upside)
Action:reiterated
Date:08/05/26

The overall score reflects a company with improving but still weak fundamentals: reduced debt and consistently positive cash flow support the balance sheet, yet persistent losses, sharply lower margins, and negative returns on equity keep financial performance only mid‑range. Technical indicators are mildly bearish, with the share price hovering below key moving averages and momentum indicators signaling lackluster demand rather than a clear rebound. Valuation is constrained by a negative P/E and no dividend, offering little compensation for the ongoing earnings risk until the turnaround translates into sustainable profitability.

Positive Factors
Cash generationConsistent positive operating cash flow and free cash flow across FY2023–FY2026 indicate the company generates cash despite accounting losses. Durable cash conversion reduces dependence on external financing, funds operations and investment, and supports deleveraging and strategic flexibility over the medium term.
Negative Factors
Persistent net losses & negative ROEMulti-year net losses and a negative return on equity signal the business has not produced shareholder returns. Persistent losses erode capital efficiency, constrain reinvestment, increase financing costs, and make it harder to justify the equity base unless profitability turns sustainably positive.

Modern Healthcare Technology Holdings Limited (0919) vs. iShares MSCI Hong Kong ETF (EWH)

-10%0%10%20%30%40%50%HK:0919+4.17%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 67.84M
Dividend Yield
―
Average Volume (3M)
280.65K
Price to Earnings (P/E)
-37.5
Beta (1Y)
0.50
Revenue Growth
-2.31%
EPS Growth
66.07%
Country
Hong Kong
Employees
783
Sector
Consumer Cyclical
Sector Strength
61
Industry
Personal Products & Services

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skinca...

How the Company Makes Money

null

Modern Healthcare Technology Holdings Limited Financial Statement Overview

Summary

Financials are mixed: the company has narrowed losses and maintains positive operating and free cash flow with reduced leverage and a solid equity base, but it still posts negative net income, sharply compressed gross margins, and negative returns on equity, indicating an incomplete and fragile turnaround despite improving cash discipline.

Income Statement

42Neutral

Balance Sheet

58Neutral

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue444.52M442.81M453.27M454.71M406.33M355.59M
Gross Profit126.99M91.89M165.26M166.96M394.72M341.52M
EBITDA113.89M108.17M77.11M95.68M70.72M26.39M
Net Income-1.76M-1.76M-5.07M-9.57M-20.61M-68.81M
Balance Sheet
Total Assets521.38M521.38M564.46M611.04M561.35M570.96M
Cash, Cash Equivalents and Short-Term Investments305.63M305.63M236.67M193.66M177.53M127.53M
Total Debt43.50M43.50M68.65M106.57M40.11M65.01M
Total Liabilities328.34M328.34M373.26M416.65M357.47M347.75M
Stockholders Equity186.68M186.68M185.85M189.33M199.77M219.58M
Cash Flow
Free Cash Flow77.06M77.06M134.94M64.08M125.52M-29.55M
Operating Cash Flow80.12M80.12M151.09M78.66M139.82M51.31M
Investing Cash Flow4.58M5.57M-50.50M8.16M-13.17M-79.96M
Financing Cash Flow-62.31M-62.31M-66.24M-70.60M-77.31M-78.46M

Modern Healthcare Technology Holdings Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.07

Price Trends

50DMA0.08Negative
100DMA0.08Negative
200DMA0.09Negative

Market Momentum

MACD-0.00Positive
RSI31.77Neutral
STOCH66.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, below the 50-day MA of 0.08, and below the 200-day MA of 0.09, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 31.77 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0919.

Modern Healthcare Technology Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:0919 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183068NeutralHKD 1.43B8.0143.78%12.76%-14.68%-13.60%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:1448HK:144856NeutralHKD 6.03B14.006.50%20.98%――
HK:8483HK:848355NeutralHKD 248.00M-24.54-77.06%―-38.43%-394.12%
HK:2521HK:252152NeutralHKD 1.80B49.266.47%―2.78%-41.23%
HK:0919HK:091951NeutralHKD 67.84M-37.50-0.93%―-2.31%66.07%
HK:8296HK:829647NeutralHKD 17.95M-0.76-17.95%―-26.00%-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

0%100%200%HK:0919HK:1448HK:1830HK:8296HK:8483HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:0919 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0919Modern Healthcare Technology Holdings Limited0.070.004.17%
HK:1448Fu Shou Yuan International Group 2.64-0.25-8.69%
HK:1830Perfect Medical Health Management Limited1.14-0.08-6.79%
HK:8296Sino-Life Group Limited0.19-0.19-50.00%
HK:8483Max Sight Group Holdings Limited0.310.22248.31%
HK:2521Shenghui Cleanness Group Holdings Limited0.930.53131.25%

Modern Healthcare Technology Holdings Limited Corporate Events

Modern Healthcare Technology Sets 2026 AGM to Approve Accounts, Board and Share Mandate

Jul 27, 2026

Modern Healthcare Technology Holdings Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates in the healthcare technology space and delivers health-focused products and services. Its corporate governance reli...

Modern Healthcare Technology Plans Governance Overhaul to Embrace Electronic and Uncertificated Securities

Jul 24, 2026

Modern Healthcare Technology Holdings Limited plans to update its amended and restated articles of association to align with the latest regulatory requirements in Hong Kong and the Cayman Islands. The proposed new articles will address electronic or...

Modern Healthcare Technology narrows annual loss as operating profit improves

Jun 30, 2026

Modern Healthcare Technology Holdings Limited reported revenue of HK$442.8 million for the year ended 31 March 2026, a slight decline from HK$453.3 million a year earlier. Despite lower revenue and reduced other income, tighter control of operating c...

Modern Healthcare Technology Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

Jun 5, 2026

Modern Healthcare Technology Holdings Limited has scheduled a board meeting in Hong Kong on 30 June 2026 to approve its annual results for the financial year ended 31 March 2026. The board will also consider the declaration of a dividend, signaling a...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 05, 2026